The research lab led by Dr. Gil Dan Rabinovici at UCSF focuses on improving the diagnosis of Alzheimer's disease and related dementias (ADRD). Their work seeks to validate accessible biomarkers and cognitive tests, particularly for underrepresented populations, to enhance diagnostic precision and inclusivity. Through collaboration with a multi-disciplinary team, they aim to develop scalable approaches to identify individuals who may benefit from disease-modifying therapies.

Dr. Thomas Link's lab at UCSF focuses on understanding how changes in body weight influence the progression of knee osteoarthritis (OA), particularly in overweight and obese individuals. The research aims to uncover the biological mechanisms behind this relationship, such as inflammation and muscle health, to develop personalized treatment strategies. By analyzing large datasets and utilizing advanced machine learning techniques, the lab hopes to create prediction models that can tailor interventions to patients, ultimately improving outcomes and preventing severe joint issues.

Dr. Michael John Evans' lab focuses on developing new radiotherapy strategies to treat prostate cancer by utilizing the unique biochemistry of human kallikrein 2 (hK2). The lab is pioneering novel low molecular weight peptides that can target cancer cells more effectively and safely, offering enhanced therapeutic benefits over current treatments. This research aims not only to improve tumor imaging and assessment but also to create targeted radiopharmaceuticals that can better deliver radiation directly to cancer cells while minimizing side effects.

Professor Brian K. Shoichet's lab focuses on creating new methods for discovering potential drugs by using computational and experimental approaches. They especially aim to understand how different molecules interact with biological targets, like proteins, to influence health and disease. The lab works on large libraries of compounds to test how changes in these libraries affect drug discovery outcomes, aiming to find new insights into drug interactions and delivery methods.

Dr. David M. Wilson's lab at UCSF focuses on developing advanced imaging techniques to enhance our understanding and diagnosis of Alzheimer's disease and other conditions. They work on creating new PET imaging tracers that can help visualize changes in brain cells associated with Alzheimer’s, as well as tracers designed to detect bacterial infections more effectively. Their research aims to bridge the gap between innovative tracer synthesis and real-world clinical applications, benefiting patients with neurological and infectious diseases.

Dr. Sharmila Majumdar's lab at UCSF focuses on understanding osteoarthritis (OA), a painful joint condition that affects millions. The lab employs advanced imaging and biomechanics techniques to track and analyze joint health over time, aiming to improve early diagnosis and intervention strategies. By studying how joint degeneration progresses, they hope to develop better preventive treatments for OA, particularly targeting those at high risk.

Dr. Elyssa Margolis' lab at UCSF focuses on understanding how specific brain circuits influence pain perception and its emotional aspects, particularly in the context of chronic pain and depression. The lab investigates the lateral habenula, a brain region involved in both sensory pain and mood disorders. By studying how this area connects to other brain structures, the lab aims to identify potential new therapies for alleviating both pain and the emotional distress that often accompanies it.

Dr. Kaitlin B. Casaletto's lab focuses on understanding how biological sex influences dementia, particularly frontotemporal dementia (FTD). They investigate the roles of sex hormones and synaptic health in cognitive resilience, aiming to unlock new strategies for the prevention and treatment of Alzheimer's disease and related forms of dementia. This research hopes to address significant gaps in the current understanding of dementia's impact on different sexes.

Dr. Wallace Marshall's lab at UCSF focuses on understanding how cells determine their shapes and structures, which are crucial for their functions. By studying model organisms and employing techniques from both biology and engineering, they investigate how cells sense and respond to changes in their geometry. Their research has important implications for understanding diseases where cell structure is altered, such as cancer.

Laura A Schmidt's research lab at UCSF focuses on innovative strategies to reduce sugary beverage consumption in workplace settings to combat obesity and related metabolic issues. The lab is conducting a comprehensive study that includes a sales ban on sugary drinks combined with motivational counseling for employees. The ultimate goal is to assess how these strategies influence health outcomes and contribute to public health.

Dr. Adrian Erlebacher's lab at UCSF focuses on understanding how the fetus and placenta evade rejection by the maternal immune system. They investigate the role of glycosylated proteins on the surface of the placenta in modulating immune responses, which has implications for pregnancy complications like preeclampsia and miscarriage. Their research combines animal models and human samples to explore these mechanisms and aims to open new avenues for developing immune tolerance therapies.

Dr. Anita Sil's lab at UCSF focuses on studying how the fungus Histoplasma capsulatum changes its form and behavior in response to temperature, which is crucial for its ability to infect humans. Their research aims to uncover the molecular mechanisms behind this transformation, including the role of specific proteins that help the fungus evade the immune system. By exploring these biological processes, the lab hopes to enhance our understanding of fungal infections and find new strategies for treating them.

Dr. Lily Jan's lab at UCSF focuses on understanding a family of proteins known as TMEM16, which play crucial roles in how neurons communicate and regulate various physiological functions. Through techniques such as cryo-electron microscopy and site-directed mutagenesis, the lab investigates how these proteins function as ion channels and lipid scramblases, contributing to exciting areas like neurodegeneration and pain sensitivity. This research is essential for uncovering the mechanisms behind human diseases linked to these proteins.

Dr. Henry Vanbrocklin's lab focuses on creating innovative ways to improve prostate cancer treatment using nanomedicines. They are developing a special type of drug that carries a PARP inhibitor to tumors more effectively and is linked with a molecular imaging tool to track its delivery. Their approach aims to enhance the effectiveness of prostate cancer therapies while minimizing side effects, potentially changing how patients are treated in the future.

Dr. Daniel B. Vigneron's lab at UCSF focuses on advancing imaging techniques for better detection and assessment of prostate cancer. They are developing innovative methods utilizing hyperpolarized carbon-13 MRI to monitor metabolic changes in tumors, especially in response to therapies like radiation. Their work aims to improve biopsy guidance and treatment planning, ultimately enhancing patient care in prostate cancer management.

Dr. Zev Jordan Gartner's lab at UCSF focuses on understanding how the tiny finger-like structures in the intestine, called villi, are formed and repaired. This is important because healthy villi are essential for absorbing nutrients, and their dysfunction can lead to serious digestive diseases. The lab combines advanced imaging techniques and mouse genetics to study the forces and signals that drive villus growth and branching. Their research could lead to new therapies for gastrointestinal diseases and strategies for tissue regeneration.

Dr. William Degrado's lab at UCSF explores how proteins work by studying their structures and functions. They focus on viral proteins, particularly those found in influenza and coronaviruses, to design new drugs that can block these viruses, especially those that have become resistant to current treatments. The lab also aims to create new proteins that can assist in drug binding and nutrient transport, contributing to advancements in therapeutic developments.

Dr. Pavithra Viswanath's lab at UCSF focuses on understanding the metabolism of brain tumors, particularly diffuse midline gliomas in children and adult gliomas with IDH mutations. The lab studies how certain metabolic processes, like glycolysis and citrate metabolism, impact tumor growth and immune response. By identifying vulnerabilities in tumor metabolism, the lab aims to develop new therapies and imaging techniques to improve survival and quality of life for patients with these aggressive cancers.

Dr. Kang Wang's lab at UCSF focuses on improving the early detection and monitoring of metastatic colorectal cancer through advanced imaging technologies. The lab is developing an artificial intelligence system designed to analyze multiple CT scans over time, which will aid radiologists in identifying subtle changes in the disease, streamline their reporting process, and enhance patient outcomes. By automating data extraction and improving the interpretation of CT images, the lab aims to ease the burden on healthcare professionals and improve the accuracy of cancer diagnoses.

Dr. William A. Weiss's lab focuses on understanding and developing new therapies for aggressive brain cancers, particularly glioblastoma and medulloblastoma. By investigating mechanisms at the molecular level, such as how specific proteins regulate cancer cell growth, the lab aims to create targeted treatments that improve patient outcomes while minimizing side effects. Current research includes developing drugs that can effectively penetrate the blood-brain barrier and inhibit key cancer drivers in the brain.